These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35918719)

  • 21. Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung Study.
    Lenoir A; Christe A; Ebner L; Beigelman-Aubry C; Bridevaux PO; Brutsche M; Clarenbach C; Erkosar B; Garzoni C; Geiser T; Guler SA; Heg D; Lador F; Mancinetti M; Ott SR; Piquilloud L; Prella M; Que YA; von Garnier C; Funke-Chambour M
    Respiration; 2023; 102(2):120-133. PubMed ID: 36566741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of impaired pulmonary function on clinical outcomes in survivors of severe COVID-19 without pre-existing respiratory disease.
    Benedetto IG; Silva RMCD; Hetzel GM; Viana GDS; Guimarães AR; Folador L; Brentano VB; Garcia TS; Ribeiro SP; Dalcin PTR; Gazzana MB; Berton DC
    J Bras Pneumol; 2023; 49(3):e20220452. PubMed ID: 37255163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mid-term pulmonary sequelae after hospitalisation for COVID-19: The French SISCOVID cohort.
    Calcaianu G; Degoul S; Michau B; Payen T; Gschwend A; Fore M; Iamandi C; Morel H; Oster JP; Bizieux A; Nocent-Ejnaini C; Carvallo C; Romanet S; Goupil F; Leurs A; Legrand MG; Portel L; Claustre J; Calcaianu M; Bresson D; Debieuvre D
    Respir Med Res; 2022 Nov; 82():100933. PubMed ID: 35905553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twelve-month clinical, functional, and radiological outcomes in patients hospitalized for SARS-CoV-2 pneumonia.
    Bongiovanni M; Barilaro G; Bini F
    J Med Virol; 2023 Feb; 95(2):e28524. PubMed ID: 36695513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between serum ferritin level and decreased diffusion capacity 3 months after the onset of COVID-19 pneumonia.
    Shinfuku K; Takasaka N; Fukuda T; Chida K; Suzuki Y; Shibata S; Kojima A; Hasegawa T; Yamada M; Yamanaka Y; Hosaka Y; Seki A; Seki Y; Takeda H; Ishikawa T; Kuwano K
    PLoS One; 2023; 18(2):e0281249. PubMed ID: 36795727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity.
    Munker D; Veit T; Barton J; Mertsch P; Mümmler C; Osterman A; Khatamzas E; Barnikel M; Hellmuth JC; Münchhoff M; Walter J; Ghiani A; Munker S; Dinkel J; Behr J; Kneidinger N; Milger K
    Infection; 2022 Feb; 50(1):157-168. PubMed ID: 34322859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.
    Wu X; Liu X; Zhou Y; Yu H; Li R; Zhan Q; Ni F; Fang S; Lu Y; Ding X; Liu H; Ewing RM; Jones MG; Hu Y; Nie H; Wang Y
    Lancet Respir Med; 2021 Jul; 9(7):747-754. PubMed ID: 33964245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for impaired respiratory function post COVID-19: A prospective cohort study of nonhospitalized and hospitalized patients.
    Björsell T; Sundh J; Lange A; Ahlm C; Forsell MNE; Tevell S; Blomberg A; Edin A; Normark J; Cajander S
    J Intern Med; 2023 May; 293(5):600-614. PubMed ID: 36815689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors.
    di Filippo L; Compagnone N; Frara S; Allora A; Doga M; Rovere Querini P; Cremona G; Giustina A
    Endocrine; 2022 Aug; 77(2):392-400. PubMed ID: 35676466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections.
    González-Islas D; Sánchez-Moreno C; Orea-Tejeda A; Hernández-López S; Salgado-Fernández F; Keirns-Davis C; Galicia-Amor S; Trejo-Mellado E; Gochicoa-Rangel L; Castorena-Maldonado A
    BMC Pulm Med; 2022 Jun; 22(1):223. PubMed ID: 35676657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary function and Quality of Life in a prospective cohort of (non-) hospitalized COVID-19 pneumonia survivors up to six months.
    de Roos MP; Siegerink S; Dijkstra NG; Broekman BF; Brinkman K; Jonkman NH; Bresser P
    Chron Respir Dis; 2022; 19():14799731221114271. PubMed ID: 36367295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Consequences of COVID-19 at 6 Months and Above: A Systematic Review and Meta-Analysis.
    Ma Y; Deng J; Liu Q; Du M; Liu M; Liu J
    Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary Function and Psychological Burden Three Months after COVID-19: Proposal of a Comprehensive Multidimensional Assessment Protocol.
    Vagheggini G; Marzetti F; Miniati M; Bernardeschi L; Miccoli M; Boni Brivio G; Meini S; Panait E; Cini E; Gemignani A
    Healthcare (Basel); 2022 Mar; 10(4):. PubMed ID: 35455789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of socioeconomic status on functional recovery after ARDS caused by SARS-CoV-2: a multicentre, observational study.
    Declercq PL; Fournel I; Demeyere M; Ksiazek E; Meunier-Beillard N; Rivière A; Clarot C; Maizel J; Schnell D; Plantefeve G; Ampere A; Daubin C; Sauneuf B; Kalfon P; Federici L; Redureau É; Bousta M; Lagache L; Vanderlinden T; Nseir S; La Combe B; Bourdin G; Monchi M; Nyunga M; Ramakers M; Oulehri W; Georges H; Salmon Gandonniere C; Badie J; Delbove A; Monnet X; Beduneau G; Artaud-Macari É; Abraham P; Delberghe N; Le Bouar G; Miailhe AF; Hraiech S; Bironneau V; Sedillot N; Hoppe MA; Barbar SD; Calcaianu GD; Dellamonica J; Terzi N; Delpierre C; Gélinotte S; Rigaud JP; Labruyère M; Georges M; Binquet C; Quenot JP;
    BMJ Open; 2022 Apr; 12(4):e057368. PubMed ID: 35459672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung diffusing capacity for nitric oxide and carbon monoxide following mild-to-severe COVID-19.
    Barisione G; Brusasco V
    Physiol Rep; 2021 Feb; 9(4):e14748. PubMed ID: 33625799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One year follow-up of physical performance and quality of life in patients surviving COVID-19: a prospective cohort study.
    Betschart M; Rezek S; Unger I; Ott N; Beyer S; Böni A; Gisi D; Shannon H; Spruit MA; Sieber C
    Swiss Med Wkly; 2021 Oct; 151():w30072. PubMed ID: 34751538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Female Sex Affects Respiratory Function and Exercise Ability in Patients Recovered from COVID-19 Pneumonia.
    Spicuzza L; Campisi R; Alia S; Prestifilippo S; Giuffrida ML; Angileri L; Ciancio N; Vancheri C
    J Womens Health (Larchmt); 2023 Jan; 32(1):18-23. PubMed ID: 36450116
    [No Abstract]   [Full Text] [Related]  

  • 39. Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study.
    Bellan M; Apostolo D; Albè A; Crevola M; Errica N; Ratano G; Tonello S; Minisini R; D'Onghia D; Baricich A; Patrucco F; Zeppegno P; Gramaglia C; Balbo PE; Cappellano G; Casella S; Chiocchetti A; Clivati E; Giordano M; Manfredi M; Patti G; Pinato DJ; Puricelli C; Raineri D; Rolla R; Sainaghi PP; Pirisi M;
    Front Immunol; 2022; 13():1038227. PubMed ID: 36601115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19-induced sarcopenia and physical deconditioning may require reassessment of surgical risk for patients with cancer.
    Casey P; Ang Y; Sultan J
    World J Surg Oncol; 2021 Jan; 19(1):8. PubMed ID: 33430881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.